Nova Cannabis Performance
| NVACFDelisted Stock | USD 1.26 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.51, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nova Cannabis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Nova Cannabis is expected to be smaller as well. At this point, Nova Cannabis has a negative expected return of -0.0404%. Please make sure to verify Nova Cannabis' kurtosis, day typical price, as well as the relationship between the semi variance and value at risk , to decide if Nova Cannabis performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Nova Cannabis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Nova Cannabis is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1.8 M | |
| Total Cashflows From Investing Activities | -12.4 M |
Nova |
Nova Cannabis Relative Risk vs. Return Landscape
If you would invest 128.00 in Nova Cannabis on September 2, 2024 and sell it today you would lose (2.00) from holding Nova Cannabis or give up 1.56% of portfolio value over 90 days. Nova Cannabis is currently producing negative expected returns and takes up 0.6614% volatility of returns over 90 trading days. Put another way, 5% of traded otc stocks are less volatile than Nova, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Nova Cannabis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Cannabis' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Nova Cannabis, and traders can use it to determine the average amount a Nova Cannabis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0611
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVACF |
Estimated Market Risk
| 0.66 actual daily | 5 95% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nova Cannabis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nova Cannabis by adding Nova Cannabis to a well-diversified portfolio.
Nova Cannabis Fundamentals Growth
Nova OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Nova Cannabis, and Nova Cannabis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nova OTC Stock performance.
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0287 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 59.13 M | |||
| Shares Outstanding | 57.15 M | |||
| Price To Book | 0.44 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 134.36 M | |||
| EBITDA | (7.32 M) | |||
| Cash And Equivalents | 6.22 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 60.11 M | |||
| Debt To Equity | 1.11 % | |||
| Book Value Per Share | 0.92 X | |||
| Cash Flow From Operations | (9.98 M) | |||
| Earnings Per Share | (0.30) X | |||
| Total Asset | 118.7 M | |||
About Nova Cannabis Performance
By analyzing Nova Cannabis' fundamental ratios, stakeholders can gain valuable insights into Nova Cannabis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nova Cannabis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nova Cannabis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nova Cannabis Inc. engages in the operation of retail cannabis stores with a focus on the recreational-use cannabis market in Canada. As of March 31, 2022, the company operated 78 cannabis stores in Alberta, Ontario, and Saskatchewan. Nova Cannabis operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 548 people.Things to note about Nova Cannabis performance evaluation
Checking the ongoing alerts about Nova Cannabis for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Nova Cannabis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nova Cannabis is not yet fully synchronised with the market data | |
| Nova Cannabis generated a negative expected return over the last 90 days | |
| Nova Cannabis may become a speculative penny stock | |
| Nova Cannabis has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 134.36 M. Net Loss for the year was (20.61 M) with profit before overhead, payroll, taxes, and interest of 24.89 M. | |
| Nova Cannabis has accumulated about 6.22 M in cash with (9.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 63.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Nova Cannabis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nova Cannabis' stock is overvalued or undervalued compared to its peers.
- Examining Nova Cannabis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nova Cannabis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nova Cannabis' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Nova Cannabis' otc stock. These opinions can provide insight into Nova Cannabis' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Nova Cannabis information on this page should be used as a complementary analysis to other Nova Cannabis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Nova OTC Stock
If you are still planning to invest in Nova Cannabis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nova Cannabis' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |